---
title: "Meet Tatiana Sampaio: the scientist who discovered polylaminin"
pubDate: 2026-02-20
brief: "Clinical trials have officially begun for Polylaminin, a specialized protein created at UFRJ that has shown potential in helping repair spinal cord lesions. The Phase 1 study, authorized by Anvisa, marks a critical step toward using this new substance as a treatment for permanent paralysis."
techRating: 3
category: ["Pharmacology", "Regenerative Medicine"]
goldenRead: true
sourceUrl: "https://en.clickpetroleoegas.com.br/polilaminina-lesoes-medulares-ufrj-anvisa-caes/"
---
